Get started
Author

Min Xu

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study
2024 · Marc Ferrante, Geert D'Haens, et al. · The Lancet · 148
PDF
Dietary eicosapentaenoic acid normalizes hippocampal omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central interleukin-1β administration
2017 · Yilong Dong, Min Xu, et al. · European Journal of Nutrition · 97
Design, Synthesis, and Biological Evaluation of Deuterated C-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes
2014 · Ge Xu, Binhua Lv, et al. · Journal of Medicinal Chemistry · 65
Effects of curcumin in treatment of experimental pulmonary fibrosis: A comparison with hydrocortisone
2007 · Min Xu, Bin Deng, et al. · Journal of Ethnopharmacology · 50
PDF
Sodium-glucose cotransporters display sodium- and phlorizin-dependent water permeability
1996 · J. D. Loike, S. Hickman, et al. · American Journal of Physiology-Cell Physiology · 46
The Melanogenesis-Inhibitory Effect and the Percutaneous Formulation of Ginsenoside Rb1
2014 · Lin Wang, Ai-Ping Lu, et al. · AAPS PharmSciTech · 42
PDF
Comparison of Sodium–Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide Receptor Agonists for Atrial Fibrillation in Type 2 Diabetes Mellitus: Systematic Review With Network Meta-analysis of Randomized Controlled Trials
2021 · Wenjie Li, Xingqing Chen, et al. · Journal of Cardiovascular Pharmacology · 37
C-Aryl glucosides substituted at the 4′-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes
2011 · Baihua Xu, Yan Feng, et al. · Bioorganic & Medicinal Chemistry Letters · 32
ortho-Substituted C-aryl glucosides as highly potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors
2010 · Baihua Xu, Yan Feng, et al. · Bioorganic & Medicinal Chemistry · 23
Conformationally Constrained Spiro C‐Arylglucosides as Potent and Selective Renal Sodium‐Dependent Glucose Co‐transporter 2 (SGLT2) Inhibitors
2010 · Binhua Lv, Yan Feng, et al. · ChemMedChem · 21
Leptin Attenuates Lipopolysaccharide or Oleic Acid-Induced Acute Lung Injury in Mice
2013 · Hai-Ying Dong, Min Xu, et al. · American Journal of Respiratory Cell and Molecular Biology · 16
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study
2021 · Linong Ji, Ying Du, et al. · Diabetologia · 12
PDF
Ferulic acid in Chaihu Shugan San modulates depression-like behavior, endothelial and gastrointestinal dysfunction in rats via the Ghrl-Edn1/Mecp2/P-mTOR/VEGFA pathway: A multi-omics study
2025 · Min Xu, Qian-tao Zhang, et al. · Journal of Ethnopharmacology · 11
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator PB-201 and its effects on the glucose excursion profile in drug-naïve Chinese patients with type 2 diabetes: a randomised controlled, crossover, single-centre phase 1 trial
2021 · Dongyang Liu, Ying Du, et al. · EClinicalMedicine · 11
Differences and Risk Factors of Peripheral Blood Immune Cells in Patients with Obstructive Sleep Apnea
2024 · Ying Jiang, Chuankai Lin, et al. · Nature and Science of Sleep · 7
PDF
Surfactant protein D is a biomarker of influenza‐related pediatric lung injury
2021 · Arindam Chakrabarti, Allen Nguyen, et al. · Pediatric Pulmonology · 7
Safety, Pharmacokinetics and Pharmacodynamics of Multiple Escalating Doses of PEGylated Exenatide (PB-119) in Healthy Volunteers
2021 · Hong Cui, Cai-Yun Zhao, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 5
Development of a PBPK model to quantitatively understand absorption and disposition mechanism and support future clinical trials for PB‐201
2023 · Miao Zhang, Zihan Lei, et al. · CPT Pharmacometrics & Systems Pharmacology · 4
PDF
Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining
2023 · Zekun Xu, Yuxuan Wang, et al. · Heliyon · 3
PDF
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study
2021 · Linong Ji, Ying Du, et al. · Diabetologia · 3
PDF
Latent profile analysis and related factors of physical activity in older adults with chronic obstructive pulmonary disease
2025 · Xin-xin Wang, Wei-hong Zheng, et al. · Heart & Lung · 2
PDF
[Equity of outpatient service utilization for hypertensive patients in community].
2018 · Min Xu, Xiaowan Wang, et al. · PubMed · 2
770-P: Efficacy and Safety of Once-Weekly PB-119 Monotherapy vs. Placebo in Chinese Patients with Type 2 Diabetes in a Randomized Controlled Trial
2023 · PEGBIO STUDY GROUP, MIN XU, et al. · Diabetes · 1
Abstract 005: Prevalence, Awareness, Treatment, and Control of Hypertension in China: The China Metabolic Risk Factor Study
2013 · Yu Xu, Yufang Bi, et al. · Circulation · 1
[Effect of lifting-thrusting reinforcing-reducing manipulations of acupuncture on serum ferritin content and total iron binding capacity in blood-deficiency syndrome rabbits].
2012 · Min Xu, An-Ping Xu, et al. · PubMed · 1
Works count: 43
Citation count: 649
H-index: 12
I10-index: 14
Year
Topic
Type